Bessemer Securities LLC Catalent, Inc. Transaction History

Bessemer Securities LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$72.36 - $113.1 $80,319 - $125,541	-1,110 Reduced 6.85%	15,095 $1.09 Million
Q2 2022 Aug 10, 2022	BUY	$87.2 - $114.05 $305,200 - $399,175	3,500 Added 27.55%	16,205 $1.74 Million
Q4 2021 Jan 31, 2022	BUY	$119.57 - $139.07 $327,502 - $380,912	2,739 Added 27.48%	12,705 $1.63 Million
Q3 2021 Nov 10, 2021	BUY	$109.17 - $142.35 $322,160 - $420,074	2,951 Added 42.07%	9,966 $1.33 Million
Q1 2021 May 13, 2021	BUY	$101.51 - $125.27 $712,092 - $878,769	7,015 New	7,015 $739,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Bessemer Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Bessemer Securities LLC with notifications on news.